Interaction Between Inducible Cyclooxygenase and Nitric Oxide Synthase in Cardiac Remodeling
诱导型环氧合酶和一氧化氮合酶在心脏重塑中的相互作用
基本信息
- 批准号:15590770
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
I. Mechanism whereby cardiac and renal fibrosis develops in COX-2^<-/-> knockout mouseIt is well known that cardiac and renal fibrosis develops in cyclooxygenase(COX)-2 knockout mouse with aging, suggesting that COX-2 expressed constitutively in the heart and kidney participants the regulation of fibrosis. To investigate role of COX-2 on the development of cardiac and renal fibrosis, we compared the expression of prostanoid synthases and matrix metalloproteinases(MMPs) between wild-type (WT) and COX-2^<-/-> mice. Eight week-old COX-2^<-/-> mice showed mild renal dysfunction (elevation in blood urea nitrogen) and thinning of renal cortex. The expression of membrane-bound PGE synthase(mPGES) and MMP-2 was decreased in the kidney of COX-2^<-/-> mice, compared with WT mice, and associated with decrease in renal PGE_2 content. Sixteen week-old COX-2^<-/-> mice showed mild interstitial fibrosis in the kidney and decreased expression of mPGES and MMP-2 even in the heart. In conclusion, PGE_2 … More derived from functionally-coupled COX-2 and mPGES is essential for resolving fibrosis in the kidney, and probably in the heart.II. Interaction between COX-2 and inducible nitric oxide synthase(iNOS) in post-infarct myocardiumRecent studies have suggested that COX-2-derived products are involved in the development of post-infarct ventricular remodeling. In addition, it is known that COX-2 protein is induced in concert with iNOS around and at the site of the infarct. Thus, we investigated the role of COX-2 and the interaction between COX-2 and iNOS in post-infarct myocardium using WT and iNOS knockout mice(iNOS^<-/->). In vivo myocardial infarction was produced by ligation of the left anterior descending coronary artery Mice were randomly divided into vehicle- and NS-398-treated groups. Seventy-two h later, infarct size was detected by TTC staining and the expression of COX-2 and iNOS proteins was examined by immunohistolochemical staining. The expression of COX-2 was increased in both strains and similar. iNOS was observed in close proximity to COX-2-positive cells at the periphery of the infarct in WT. There is no difference in infarct size and the mortality between WT and iNOS^<-/-> mice treated with vehicle. Administration of NS-395 tended to reduce infarct size in WT mice but it rather exacerbated infarct size and the mortality in iNOS^<-/-> mice. We speculate that 1)increased COX-2 protein has the deleterious effect in post-infarct myocardium and 2)co-expressed iNOS modulates the deleterious effect of COX-2. Thus, COX-2 might exert the cardioprotective or detrimental action, dependent on iNOS activity. Less
1 . COX-2^<-/->基因敲除小鼠心脏和肾脏纤维化发生机制众所周知,环氧化酶(COX)-2基因敲除小鼠随着年龄的增长,心脏和肾脏纤维化发生,提示心脏和肾脏中COX-2组成性表达参与了纤维化的调控。为了研究COX-2在心脏和肾脏纤维化发展中的作用,我们比较了野生型(WT)和COX-2^<-/->小鼠中前列腺素合成酶和基质金属蛋白酶(MMPs)的表达。8周龄COX-2^<-/->小鼠出现轻度肾功能障碍(血尿素氮升高)和肾皮质变薄。COX-2^<-/->小鼠肾脏中膜结合PGE合成酶(mPGES)和MMP-2的表达较WT小鼠降低,且与肾脏PGE_2含量降低有关。16周龄COX-2^<-/->小鼠肾脏出现轻度间质纤维化,mPGES和MMP-2的表达甚至在心脏也下降。综上所述,PGE_2…More来源于功能偶联的COX-2和mPGES,对于解决肾脏纤维化至关重要,也可能是心脏纤维化。COX-2与诱导型一氧化氮合酶(iNOS)在梗死后心肌中的相互作用最近的研究表明,COX-2衍生产物参与了梗死后心室重构的发展。此外,已知COX-2蛋白与梗死周围和部位的iNOS协同诱导。因此,我们利用WT和iNOS敲除小鼠(iNOS^<-/->)研究了COX-2在梗死后心肌中的作用以及COX-2与iNOS之间的相互作用。小鼠随机分为给药组和ns -398组。72h后,TTC染色检测梗死面积,免疫组化染色检测COX-2和iNOS蛋白表达。COX-2的表达在两株和相似株中均有升高。在WT梗死周围cox -2阳性细胞附近观察到iNOS。与iNOS^<-/->小鼠相比,WT和iNOS^<-/->小鼠的梗死面积和死亡率没有差异。NS-395在WT小鼠中有减小梗死面积的趋势,但在iNOS^<-/->小鼠中却增加了梗死面积和死亡率。我们推测1)COX-2蛋白的增加对梗死后心肌具有有害作用,2)共表达的iNOS调节COX-2的有害作用。因此,COX-2可能发挥心脏保护或有害作用,这取决于iNOS的活性。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Direct activation of PKC-epsilon or mitochondrial KATP channels mimics ischemic preconditioning in the ovariectomized rat heart.
PKC-ε 或线粒体 KATP 通道的直接激活模拟了去卵巢大鼠心脏的缺血预处理。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Shinmura K;Nagai M;Tamaki K.
- 通讯作者:Tamaki K.
Loss of ischemic preconditioning in the ovariectomized rat : Possihie in volvement of impaired phosphorylation of serine^<729> residue of PKC-ε.
切除卵巢的大鼠中缺血预适应的丧失:可能涉及PKC-ε的丝氨酸^<729>残基的磷酸化受损。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Shinmura K;Nagai M;Tamaki K;Bolli R.
- 通讯作者:Bolli R.
Possible Mechanisms of Cyclooxygenase (COX)-2 Hazard : Is C0X2 in the Cardiovascular System a Friend or a Foe?
环加氧酶 (COX)-2 危害的可能机制:C0X2 在心血管系统中是朋友还是敌人?
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Shinmura K;Tamaki K;Sato T;Ishida H;Bolli R.;Shinmura K.
- 通讯作者:Shinmura K.
Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts
- DOI:10.1016/j.yjmcc.2005.03.010
- 发表时间:2005-08-01
- 期刊:
- 影响因子:5
- 作者:Shinmura, K;Tamaki, K;Bolli, R
- 通讯作者:Bolli, R
心血管系におけるシクロオキシゲナーゼ(COX)-2は敵か味方か?:COX-2ハザードの分子メカニズム
环氧合酶 (COX)-2 在心血管系统中是朋友还是敌人?:COX-2 危害的分子机制
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:新村 健
- 通讯作者:新村 健
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHINMURA Ken其他文献
SHINMURA Ken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHINMURA Ken', 18)}}的其他基金
Prediction and prevention of frailty from the lifestyle investigation in rural Japanese community-dwelling older adults
通过日本农村社区老年人的生活方式调查预测和预防衰弱
- 批准号:
16KT0012 - 财政年份:2016
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Evaluation of mechanisms by which caloric restriction regulates mitochondrial function
热量限制调节线粒体功能的机制评估
- 批准号:
22590814 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Search for plant-derived arginine-dependent nitric oxide synthase by purine metabolites
通过嘌呤代谢物寻找植物来源的精氨酸依赖性一氧化氮合酶
- 批准号:
22K19174 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identification and elaboration of fluorine containing inhibitors of proline rich tyrosine kinase and endothelial nitric oxide synthase
富含脯氨酸酪氨酸激酶和内皮一氧化氮合酶的含氟抑制剂的鉴定和精制
- 批准号:
2743764 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Studentship
Regulation and function of human inducible nitric oxide synthase
人诱导型一氧化氮合酶的调节和功能
- 批准号:
RGPIN-2019-05192 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Regulation and function of human inducible nitric oxide synthase
人诱导型一氧化氮合酶的调节和功能
- 批准号:
RGPIN-2019-05192 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Investigation of Nitric Oxide Synthase Structure, Function and Inhibition
一氧化氮合酶结构、功能及抑制作用的研究
- 批准号:
RGPIN-2017-04007 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Regulation and function of human inducible nitric oxide synthase
人诱导型一氧化氮合酶的调节和功能
- 批准号:
RGPIN-2019-05192 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Investigation of Nitric Oxide Synthase Structure, Function and Inhibition
一氧化氮合酶结构、功能及抑制作用的研究
- 批准号:
RGPIN-2017-04007 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Clarification of the mechanism for beta-3 adrenergic receptor regulation of Inducible nitric oxide synthase in septic cardiomyopathy
阐明脓毒症心肌病中诱导型一氧化氮合酶的β3肾上腺素受体调节机制
- 批准号:
20K17852 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the role of the nitric oxide synthase system in the pathogenesis of respiratory diseases
阐明一氧化氮合酶系统在呼吸系统疾病发病机制中的作用
- 批准号:
19K08657 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective inhibition of nitric oxide synthase for multiple indications
选择性抑制一氧化氮合酶用于多种适应症
- 批准号:
10385805 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别: